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Glass scaffoldsThe interplay between glass chemistry, structure, degradation kinetics, and biological activity provides ﬂexibility
for the development of scaffolds with highly speciﬁc cellular response. The aim of this study was therefore to in-
vestigate the role of titania inclusion into the phosphate-based glass on its ability to stimulate osteoblast-like
human osteosarcoma (HOS) cells to adhere, proliferate and differentiate. In depth morphological and biochem-
ical characterisation was performed on HOS cells cultured on the surface of glass discs. Cell proliferation was also
studied in the presence of the glass extract. Cell differentiation, through osteoblast phenotype genes, alkaline
phosphatase (ALP) activity and osteocalcin production, was carried out using normal or osteogenic media. Both
Thermanox® and titania free glass were used as controls. The data demonstrated that titania inclusion provides
desired cytocompatible surface that supported initial cell attachment, sustained viability, and increased cell pro-
liferation similar or signiﬁcantly higher than Thermanox®. The modiﬁed glasses regulated osteoblastic cell dif-
ferentiation as detected by osteoblast phenotype gene transcription and upregulated ALP and osteocalcin
expression. Using osteogenic media had no signiﬁcant effect on ALP activity and osteocalcin expression. There-
fore, titania modiﬁed phosphate glasses may have future use as bone tissue engineering scaffolds.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Bone regeneration is a natural process that occurs during bone
remodelling.Where the defects are too large, however, the bone cannot
heal itself. Bone tissue engineering has emerged as a promising route to
stimulate the regenerative capacity of host bone cells to form new bone
[1]. Bone tissue engineering utilises three-dimensional natural or
synthetic scaffolds to provide the suitable environment for host cells
to grow, and hence, proceed in tissue regeneration. These scaffolds are
required to provide structural support for the host bone cells and should
favourably affect bone formation by stimulating rapid cell adhesion,
proliferation and ﬁnally regulate osteoblastic differentiation [2].
The fact that the major components of most phosphate-based
glasses (e.g., phosphorus, sodium and calcium oxides) are also found
in the inorganic phase of bone is a major contributing factor for theerms of the Creative Commons
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lished by Elsevier B.V. All rights reserbioactivity of these glasses. Ions released from degradable glasses can
modulate the host bone cells response [3–9], and they could be involved
in various cellular processes at different levels [10]. For example,
calcium “Ca” supports osteoblast proliferation, differentiation and
extracellular matrix mineralisation; it also stimulates the Ca-sensing
receptors in bone cells and subsequently increases growth factor
expression e.g., IGF-I and IGF-II [11]. Inorganic phosphate “P” stimulates
the expression of Gla protein (MGP) which is a key regulator in bone
formation [12]. Accordingly, the control of the glass dissolution rate
and hence the metallic ion release could be an attractive approach to
drive the biological response in the desired route [10].
The interplay between glass chemistry, degradation kinetics, and
biological response provides a wealth of information for the develop-
ment of scaffoldswith highly speciﬁc cellular response [13,14]. Titanium
is a transition metal; it is highly reactive as an element and spontane-
ously forms a stable ‘native’ oxide layer (~3–7 nm thick) on its surface
[15]. This oxide layer acts as an inorganic substrate that attracts
molecules, proteins and then cells to attach and ﬁnally form bone [16].
Hence this oxide layer has been credited to the ability of titanium
implants to facilitate bone apposition. Thus titanium-containing
materials/implants have been successfully used in various craniofacial
and orthopaedic applications [17,18]. Also other phosphate glasses of
more complex composition have been investigated and found suitable
for tissue engineering applications [9,19,20].ved.
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phosphate-based glasses [50 mol% P2O5, 40 mol% CaO, Na2O (10 − x),
and TiO2 (x) where x varied from 1 to 5 mol%] has been reported to
encourage attachment and viability of human osteosarcoma (HOS)
cells. Increasing titania content (from1 to 5 mol%) had a profound effect
on cytoskeleton organisation, spreading and maturation of primary
osteoblasts [5,21]. Currently, glass microspheres of approximately
10–200 μm in diameter based on the same system but with higher
titania content (3–7 mol%) show considerable potential for use in a
whole host of biomedical applications ranging from cancer radiotherapy
and thermotherapy, to drug and protein delivery or bone tissue engi-
neering applications [8]. The inclusion of titania into another relatively
more degradable glass system [50 mol% P2O5, 30 mol% CaO, Na2O
(20 − x), and TiO2 (x) where x varied from 1 to 5 mol%] that released
higher level of Ti ions (e.g., 5 mol% titania containing glass of this system
release at 0.0085 ppm·h−1 instead of 0.0051 ppm·h−1 for the same
titania content in the previous system) also improvedMG63 cell attach-
ment, proliferation and osteoblast phenotype gene expression aswell as
the in vivo bioactivity of these glasses [5]. Inclusion of up to 15 mol%
titania, the maximum possible content, has been attempted with this
glass system to produce further control on glass structure and proper-
ties. The network structure and properties of this system containing
up to 15 mol% titania have been elucidated using diverse analytical
techniques [3], but its cytocompatibility has not yet been assessed.
From a materials science perspective, slight changes in glass composi-
tion produce major changes in glass structure, degradation, ion release
and consequently biological response [6,22]. The aim of this study
was therefore to, for the ﬁrst time, assess the biocompatibility of
phosphate-based glasses doped with the maximum possible titania
content [50 mol% P2O5, 30 mol% CaO, Na2O (20 − x), and TiO2 (x)
where x varied from 5 to 15 mol%]. The inﬂuence of several glass char-
acteristics and its degradation products on viability, proliferation and
differentiation of osteoblast-like human osteosarcoma (HOS) cells has
been investigated.
2. Materials and methods
2.1. Production of glasses
Using the precursormaterials NaH2PO4, CaCO3, P2O5, and TiO2 (BDH,
Poole, UK, all chemicalswereN98% purity), four glass compositionswith
different titania (TiO2) contents were produced by melt-quenching as
described previously [3,4]. The P2O5 and CaO contents were ﬁxed at
50 and 30 mol% respectively, while the Na2O and TiO2 contents varied.
TiO2 contents were 5, 10 or 15 mol% and accordingly the Na2O contents
were 15, 10, or 5 mol% respectively. The melting temperature of the as-
prepared glasseswas 1300–1350 °C. Themelted glasswas poured into a
preheated graphitemould and annealed at 420 °C for 1 h to remove any
stresses due to preparation and then slowly cooled to room tempera-
ture. These glasses were coded as PCN, PCNT5, PCNT10 and PCNT15
respectively. Discs of 15 mm in diameter and approximately 1 mm in
thickness were used. The discs were polished using waterproof silicon
carbide papers P# 120 for 30 s at 300 RPM, then P# 500, 1000 and
2400 for 1 min each and ﬁnally P# 4000 for 2 min to get a mirror-like
surface on a Struers Rotopol-11 (Struers, UK).
2.2. Human osteosarcoma cell culture
Humanosteosarcoma (HOS) cellswere cultured at 37 °C in a humid-
iﬁed atmosphere of 5% CO2 in air, in growth medium [Dulbecco's
modiﬁed Eagle's Medium (DMEM, Gibco), supplemented with 10%
foetal calf serum, and 1% penicillin and streptomycin solution (Gibco)].
The medium was changed at 2 day intervals.
All samples for biocompatibility tests were sterilised by dry heating
at 180 °C for 3 h, and pre-incubated in 2 ml of growthmedium for 24 h
at a 37 °C humidiﬁed atmosphere of 5% CO2 in air. Both titania free glass(PCN) and Thermanox® were used as controls. Cells were plated at a
density of 3 × 104 cells/well in 24-well culture plates that provided a
snug ﬁt of the discs, in a 50 μl aliquot ofmedium (for initial attachment)
prior to the addition of 1.5 ml of growth medium.
2.3. Cell viability and live dead staining
Determination of cell viability was carried out by incubating the
specimens for 1 h in a standard growth medium containing 1 μl/ml
calcein AM (acetomethoxy) to stain the live cells, and propidium iodide
to stain the dead cells. The assessment of cell viability in three dimen-
sions was performed using confocal laser scanning microscopy (CLSM,
Bio-Rad, USA).
2.4. Cell proliferation assay
This study was carried out by growing HOS cells either directly on
glass discs or in the presence of glass extracts. The extracts were
produced by incubating glass discs in growth medium for 24 h. For
the extract study, normal growth medium was used as a control. The
proliferation assay was conducted up to 21 days for the direct study
but only 7 days for the indirect one. At the required time point, the
cultured cells were incubated in 10% alamarBlue® (Invitrogen, UK) for
4 h according to the manufacturer's instructions. The absorbance of
the samples (n = 3 and duplicate reading for each one) was measured
at 530 nm (A530) and 590 nm (A590) as excitation and emission wave-
length using a Fluoroskan Ascent plate reader (Labsystems, Helsinki,
Finland). The cell growth was presented as the average intensity of six
replicate wells that was base line corrected and compared to the posi-
tive control cells.
2.5. Cellular differentiation
2.5.1. Gene expression
For this study, only titania containing glasses, coded as PCNT5,
PCNT10 and PCNT15, were used and compared with Thermanox®. At
1 and 14 days, the total RNA was isolated from the lysed [with
RLT-buffer (Qiagen, Germany) and β mercaptoethanol (Sigma)] and
homogenised cells using RNeasy minikit (Qiagen) and eluted with
30 μl RNase-free water. RNA concentration was calculated by using
Quanti IT™ RNA assay kit with the Qubit™ ﬂourometer (Molecular
Probes™, Invitrogen). Subsequently, the extracted total RNA was
reverse-transcribed into cDNA using a high capacity cDNA archive kit
(Applied Biosystems, Cheshire, UK) and an Eppendorf thermal cycler
(Mastercycler, Eppendorf UK Ltd., Cambridge, UK). Sampleswere stored
at−70 °C for further analysis.
cDNA for each sample was then ampliﬁed by real-time PCR-ABI
PRISM®7300 sequence detection system (Applied Biosystems, Cheshire,
UK) using human TaqMan® gene expression assay (Applied Biosystems,
Cheshire, UK). Conjugated to FAM (6-carboxyﬂuroescein) reporter dye,
TaqMan® probes (Applied Biosystems, Cheshire, UK) were used to
target corresponding nucleotide sequences for osteoblast phenotype
genes [alkaline phosphatase (ALP), collagen type I alpha subunit I
(COLIaI), core binding protein factor alpha 1 (Cbfa1) and osteonectin
(Sparc)] in the cDNA single strands. Relative quantiﬁcation Q-PCR,
using the 7300 SDS software, was conducted against the expression of
rRNA encoding housekeeping gene, 18s.
2.5.2. Alkaline phosphatase activity
For cell culture used in this study, both aforementioned normal
growth medium (non-osteogenic), and osteogenic medium (prepared
by adding 50 μg/ml ascorbic acid and 5 mM Na-β glycerophosphate to
the normal growth medium) were used.
After 1, 7 and 14 days, the culture supernatants were removed and
used for osteocalcin assay; sampleswerewashedwith phosphate buffer
solution (PBS) (Gibco, UK) and then solubilised with 1% Triton-X by
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the freshly prepared assay buffer solution (mixture of 0.4 mM
diethanolamine-HCl (pH 10.0), distilled water, 2 mM magnesium
chloride and 4 mM paranitrophenolphosphate (p-NPP) that was used
as a substrate) were added to each well in a 96-well plate. After
30 min of incubation at 37 °C, the enzymatic reaction was terminated
by adding 150 μl/well of 1 M NaOH. Enzyme activity was quantiﬁed
by absorbance measurements at 405 nm using a 96-well microplate
reader (Fluoroskan). Optical density was measured in reference to a
control sample containing the substrate solution (50 μl p-NPP),
Triton-X (50 μl) and 1 M NaOH (150 μl). The ratio of enzyme activity
(nmol of p-NPP/ml) to the mass of protein (μg) was determined [21].2.5.3. Osteocalcin assay
The concentration of osteocalcin in the isolated culture supernatants
was obtained using Gla-type osteocalcin EIA (TaKaRa Bio) assay with
lyophilised Gla-OC (glutamic acid, osteocalcin) standard according to
themanufacturer instructions. The absorbance was spectrophotometri-
cally measured and the total osteocalcin content was evaluated using
calibration curve. The assay is calibrated using human osteocalcin stan-
dards (0–32 ng/ml) [21].PCN PCNT5                                   PCN
a
b
Fig. 1. (a) Photograph showing glass discs and rods. (b) CLSM images showing the viability of H
positive control. Live cells are stained green,while dead cells are stained red. (For interpretation
this article.)2.6. Statistical analysis
Statistical analysis was applied using a one way ANOVA test using
SPSS 16.0 (UK Ltd., UK) followed by Dunnett (2-sided) t-test that treat-
ed Thermanox®andday 1 as a control. Themeandifferencewas consid-
ered to be signiﬁcant at 0.05 and 95% conﬁdence interval.3. Results
3.1. Cell viability and live dead staining
Fig. 1 shows confocal laser scanning microscopy (CLSM) images of
live/dead stained HOS cells attached to the surface of the tested glass
compositions and Thermanox® after 1 and 7 days of culture. After
1 day of culture, there were fewer live cells attached to the surface of
PCN glasses than those on the positive control surface. In contrast, a
higher number of viable cells attached to the surfaces of PCNT5,
PCNT10 and PCNT15, indicated by higher cell density, than those
attached to the positive control. After 7 days of culture, the number of
live cells remained attached to the surface of PCN glass, and has been
reduced, but no dead cellswere detected. On all titaniamodiﬁed glasses,T10 PCNT15 Thermanox®
OS cells cultured on the surface of different glass compositions compared to Thermanox®
of the references to colour in this ﬁgure legend, the reader is referred to theweb version of
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three dimensional network covering the whole glass surface in a
manner comparable to the positive control sample. Few dead cells
were also seen attached to the surface of titania modiﬁed glasses.
3.2. Cell proliferation assay
Fig. 2 shows the overall metabolic activity of HOS cells grown
directly on the pre-treated surface of tested and control samples
(Fig. 2a) as well as in the presence of glass extract or the normal tissue
culturemedia as a control (Fig. 2b). Generally PCN showed signiﬁcantly
lower cell growth than Thermanox® at the studied time points
(p b 0.0001). All titania containing glasses, however, showed no
signiﬁcant differences from Thermanox® at all time points except at
day 5 where PCNT5 showed signiﬁcantly higher cell growth than
Thermanox® (p b 0.0001). Moreover, the cell number increased with
time on titania containing glasses and Thermanox®. At a later time
point, 14 and 21 days in particular, there was no signiﬁcant difference
observed among titania containing samples (Fig. 2a). This could be
associated with the fact that the cells reached conﬂuence by day 7 of
culture as reﬂected from confocal images. This ﬁnding demonstrates
high efﬁcacy of the titania glass to support proliferation of the cells.
Regardless of the signiﬁcant (p b 0.0001) lower cell growth at day 1,
the extracts of titania containing glasses supported a similar or signiﬁ-
cantly higher cell number than the control cells at days 5 and 7. The
extract of PCNglass, however, resulted in signiﬁcantly lower cell growth
till 7 days of culture (Fig. 2b).
3.3. HOS cell differentiation
3.3.1. Gene expression
Fig. 3a shows the relative quantiﬁcation of ALP gene expression for
cells seeded on PCNT5, PCNT10 and PCNT15 and Thermanox® after 1
and 14 days in culture. There was an increase in the transcription
level of ALP at day 14 compared to day 1; this increase was only signif-
icant (p b 0.05) for the positive control and PCNT5. COL1a1, was also
up-regulated at day 14; this up-regulation was statistically signiﬁcant
for all tested glasses but insigniﬁcant (p ≥ 0.05) for the positive control
(Fig. 3b). Cbfa1 showed an exactly similar trend to ALP — Fig. 3c.
Although the transcription of Sparc increased at day 14 on all tested
glasses and positive control, but this increasewas not statistically signif-
icant (Fig. 4d).
Comparing the gene transcription level on titania containing glasses
with Thermanox®, there was no statistical signiﬁcant difference
(p ≥ 0.05) between the tested glasses and positive control except for
PCNT5 at day 1 that showed a signiﬁcantly higher ALP transcription0
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Fig. 2. Relative growth of HOS cells (a) seeded on the surface of different glasses or (b) in the p
cells. The ratios of the mean absorbance of test cells to that of positive control cells were pres
* showed the signiﬁcant difference from Thermanox®; the signiﬁcance level was set at 0.05.level. A similar ﬁnding was also observed for COL 1a1, but PCNT5
showed a signiﬁcantly higher level than Thermanox® at day 14. For
Cbfa1, however, all tested glasses showed a statistically signiﬁcantly
higher level than positive control at day 1, but not at day 14. Sparc
showed the opposite trend to Cbfa1 at day 1, but similar trend at day 14.
3.3.2. Alkaline phosphatase activity
Fig. 4a–b show ALP expression after 1, 7 and 14 days of culture
in both non-osteogenic and osteogenic media. As seen, there was no
signiﬁcant difference in ALP activity between osteogenic or non-
osteogenic at different times of culture. Furthermore, there was a signif-
icant increase in ALP activity at days 7 and 14 compared to day 1; the
difference however was not signiﬁcant between ALP expression at
days 7 and 14 for tested glasses and control. The ALP expression of
HOS cells grown on PCNT5 and PCNT10 was not signiﬁcantly different
from that on Thermanox® at days 7 and 14. At day 1, however, ALP
expression on these glasses was signiﬁcantly lower than that of
Thermanox®. ALP expression on PCNT15 was not signiﬁcantly different
from that on Thermanox® at the studied time point.
3.3.3. Osteocalcin expression
Fig. 4c–d show osteocalcin expression after 1, 7 and 14 days of
culture in both non-osteogenic and osteogenic media. Generally,
osteocalcin expression in the presence of non-osteogenic media was
higher (but does not necessarily prove to be signiﬁcant) or comparable
to that in osteogenic media i.e., there was no clear difference in
osteocalcin expression in the presence of either osteogenic or non-
osteogenic media. Moreover, there was no signiﬁcant difference in
osteocalcin expression on tested glasses and control when both osteo-
genic and non-osteogenic media were used for culture. Osteocalcin
was mostly expressed at day 1 and then its amount slightly decreased
with time but this was not signiﬁcant; this was true for tested glasses
and Thermanox®.
4. Discussion
An ideal biomaterial for bone tissue engineering should provide the
appropriate signals for osteogenesis i.e., cell attachment/proliferation/
differentiation, extracellular matrix formation and mineralisation. This
study evaluated the biocompatibility of titania containing phosphate-
based glasses, developed for potential bone tissue engineering applica-
tion. For the evaluation of their biocompatibility and efﬁcacy to promote
cell proliferation and differentiation, HOS cells were cultured on their
surface. Cell viability was investigated by live/dead staining and confo-
cal laser scanning microscopy. For the evaluation of cell proliferation,
HOS cells were incubated in vitro either in direct contact with the0
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Fig. 3. Expression of osteoblast phenotype genes ALP (a), COL1a1 (b), Cbfa1 (c) and Sparc (d) of HOS cells grown on the surface of titania containing glasses and Thermanox® over a period
of 14 days relative to 18s. All values are presented as the mean ± standard deviation. * showed the signiﬁcant difference from Thermanox®; the signiﬁcance level was set at 0.05.
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was considered as a model to simulate the in vivo environment where
the material surface and its degradation products, which lead to a
change in the concentration of ions in the surrounding environment,
have a profound effect on cellular response. The difference between
direct and indirect test should be, however, taken into consideration
during data analysis and designing of thematerial for tissue engineering
application. In direct proliferation, the cell response could largely be
inﬂuenced by substrate properties such as surface roughness, stiffness,
chemistry, free energy, and charge; all these factors are absent in the
case of the extracts. Furthermore, the local conditions such as pH and
ionic concentration are different in both cases [23]. The contact angle
of these glasses was around 35° as reported previously [3]. The rough-
ness of those samples however was b0.5 nm [3].
A number of studies have shown that the ionic product of
degradation has an effect on cell proliferation and gene expression–
differentiation. The ionic products may result in a gradient of pH
in the culture medium with a signiﬁcant shift near the surface as a
consequence undesired cell response could occur [24]. Pre-immersion
treatment of implantable devices including bioactive glasses in culture
medium has been shown to improve cell response predominantly by
pre-adsorbed proteins and inorganic component from the medium,
which form a thin ﬁlm on the surface of the device [25]. This ﬁlm is
capable of modulating cell behaviours e.g., cell-adhering ﬁbronectin
[26,27]. Furthermore, pre-immersion in culture media allows the
release of the undesirable ionic products from the material and the
adjustment of the surrounding pH [28]. Pre-conditioning of glass
samples in the culture medium for 24 h has been therefore attempted
before any cell culture study. Yet, the effect of the ionic products
released from these glasses during pre-conditioning on cell proliferation
has been considered throughout this study.Previous studies on these glasses have employed osteoblast cell
lines, MG63, and the results showed that these compositions were
biocompatible with MG63 for the time of the experiment (7 days) [3].
Hereby, HOS cells were employed due to their extensive use as a
model for the investigation of osteoblastic response to various biomate-
rials, and the fact that they express a number of features characteristic
to osteoblasts [29–31]. The high viability of HOS cells grown on titania
containing glasses indicated the suitability of these surfaces for cells to
attach and grow. The PCN surface however could not support the
attachment of HOS cells. Limited cell attachment and subsequent
proliferation are likely to be caused by the high degradation rate of
this glass system, which prevents stable anchoring of the cells on the
surface. These ﬁndings are in agreement with previous studies [3,32].
Accordingly, PCN glasses were excluded from further experiment.
The improvement of the overall metabolic activity of HOS cells
grown on the surface of titania containing glasses could be due to the
early enhanced adhesion of HOS cells onto the glass surface. Cell adhe-
sion and spreading are the initial events during cell-biomaterial interac-
tions, which affect the long term function such as cell proliferation,
synthesis of protein and calcium mineral deposition [33]. Cell adhesion
could be also correlated with the hydrophilic nature of the glass surface
[3] as well as its degradation [3,4]. Accordingly, the mobile surface of
PCN did not support cell adhesion and growth. This ﬁnding was also
supported by the absence of live cells attached to PCN glasses at day 7
of culture. The incorporation of titania provides a control on the glass
degradation; this was suggested to be due to the formation of hydration
resistant Ti\O\P instead of hydration susceptible P\O\P bonds [3,4].
Themobile surface is not the only factor that could affect cell attach-
ment and proliferation but the ions released from the material as well.
The extract of PCN glasses did not support the proliferation of HOS
cells unlike the rest of the tested glasses and the normal tissue culture
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from PCNT5, PCNT10 and PCNT15 glasses were responsible for the
enhancement of cell growth in these glass extracts, similar to the
normal tissue culture medium. As mentioned above, the control of the
glass dissolution rate and hence the metallic ion release can be consid-
ered as an attractive approach to drive the biological response in the
desired route [10].
The role of Ti in bone formation and mineralisation has been
researched in a number of studies [6,34,35]. It has been shown that Ti
ions at a speciﬁc concentration stimulated the ALP, osteopontin and
osteonectin i.e., acts as promoters of osteoblast differentiation. Above
this concentration, however, Ti will have a cytotoxic effect on bone
cells. It has been reported that 200 μmol/l of Tiwas considered cytotoxic
to ROS 17/2.8 osteoblast-like cell line [36]. In another study, ≥10 ppm
of Ti ions, which is equivalent to ≥200 μmol/l, in the tissue culture
medium inhibited proliferation of rat calvarial osteoblasts. While,
≤5 ppm Ti ions, which is equivalent to ≤100 μmol/l, either had no
effect or stimulated rat calvarial osteoblast proliferation but did not
affect the number of formed nodules. The optimumTi ion concentration
for optimum osteoblast proliferation was 1 ppm, which is equivalent to
20 μmol/l [37]. It has been also shown that Ti has an effect on bone for-
mation indirectly by affecting the behaviour of osteoclasts. For example,
Ti ions in a concentration which is 30–40 times higher than that
required to affect osteoblasts produced an apoptosis-linked preferential
degradation effect on osteoclasts [37]. In a more recent study, 1–9 ppm
of Ti ions had no signiﬁcant effect on osteoblastic MC3T3-E1, osteoclas-
tic RAW264.7 and epithelial cell-like GE-1 viability, but 20 ppm
produced a signiﬁcant reduction in their viability [38]. As reported pre-
viously, the Ti release from titania modiﬁed glasses used in this studyreached a maximum of 3 ppm after 3 weeks in deionised water [3].
Accordingly, this level of Ti release falls in the stimulatory range as
highlighted above; this could explain the signiﬁcant improvement in
cell proliferation observed with titania containing glasses compared to
the parent titania free ones.
In addition to the proliferation characteristics, an analysis of the
osteogenic potential of HOS cells using gene expression, ALP activity
and osteocalcin protein expression helps to determine the extent of
their differentiation. Osteocalcin is also known as GLa protein; it is a
bone speciﬁc protein and therefore has been recognised as a sensitive
and speciﬁc marker of osteoblast activity [39]. Osteocalcin has high
afﬁnity to Ca or hydroxyapatite [40]. The osteocalcin assay was used
to determine the osteogenic differentiation of the supernatant culture
medium removed from each studied glass and Thermanox®. This
assay is a competitive immunoassay that uses osteocalcin coated strips,
amouse anti-osteocalcin antibody, an antimouse IgG-alkalinephospha-
tase conjugate and a p-nitrophenyl phosphate (pNPP) substrate tomea-
sure “de novo” intact osteocalcin. Titania modiﬁed glasses showed
comparable ALP activity and osteocalcin expression to the positive
control surface. This indicated that titania modiﬁed glasses supported
differentiation of osteoblasts starting from increased cell density and
then upregulated expression of bone markers (osteoblast phenotype
genes, ALP and osteocalcin protein). The ﬁnal stage of differentiation,
mineralisation, was beyond the scope of this study. The absence of oste-
ogenicmedia had no effect on ALP activity and osteocalcin expression; a
similar ﬁnding was also observed for HOS cells cultured on Ni–Ti alloy
surface exposed to different modiﬁcations [21]. This could be due to
the nature of human osteosarcoma (HOS) cells. Although these cells
maintain their phenotype at high subpassages, they do not express all
313E.A. Abou Neel et al. / Materials Science and Engineering C 35 (2014) 307–313the characteristic features of osteoblasts e.g., they are not capable of
producing mineralised matrix, the ﬁnal stage of differentiation [41].
However, due to their versatility and extensive use in research studying
the osteoblasts' response to various biomaterials [21,42–44] they have
been used in this study as highlighted above.
5. Conclusion
Modiﬁcation of the glass network with 5 to 15 mol% titania
produced generally cytocompatible substrates that allow the desired
cell adhesion, sustained viability and high proliferation, and promote
differentiation of human osteosarcoma (HOS) cells. This improved bio-
logical response of titania containing glasses could be associated with
the release of Ti ions which has been previously shown to affect bone
cell function. The Ti release from these glasses falls in the range that
has been reported to stimulate osteoblasts or osteoblast-like cell func-
tion. This ﬁnding suggested that titania modiﬁed phosphate-based
glasses may have future implications as a scaffold for bone tissue engi-
neering applications.
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